About Careers Internship MedBlog Contact us

Novel Approach to Fight HIV may Help in Development of Vaccine

by Savitha C Muppala on September 28, 2010 at 6:28 PM
Font : A-A+

 Novel Approach to Fight HIV may Help in Development of Vaccine

A new way of fighting HIV by preventing shape-shifting in an important segment of protein from HIV, may help prime the immune system to develop antibodies against the virus, and pave the way for the development of an AIDS vaccine.

Such antibodies, elicited against specific protein segments, could one day serve as the basis for a vaccine to fight many different strains of HIV or other swiftly mutating viruses.


Although a small percentage of individuals infected with HIV develop 'broadly neutralizing antibodies' that disarm different strains of the virus, researchers have so far been unable to develop a vaccine that coaxes the immune system into making such antibodies.

To get around this problem, researchers have tried to extract a key bit of protein - or epitope - that a neutralizing antibody recognizes, in the hope that the immune system will react more strongly to the epitope in isolation.

However, without the rest of the protein to hold it in place, the segment generally loses its recognizable stable structure.

Now, scientists in the United States have devised a computer model for identifying a protein that could serve as a type of scaffold, locking an epitope into the structure to which a neutralizing antibody can bind.

"We've figured out how to pull out those snippets, retain their structure, and teach the immune system to recognize them," Nature quoted Peter Kwong, a structural biologist at the National Institute of Allergy, as saying.

The researchers tested the approach on an epitope of gp41, a protein on the surface of HIV that helps the virus to invade and infect host cells.

The epitope is recognized by an antibody called 2F5, which can neutralize several strains of the virus.

After extracting the epitope from the virus, the researchers transplanted the epitope onto a protein with a complementary structure that acted as the scaffold.

The immune systems of guinea pigs injected with this scaffold-epitope complex developed antibodies very similar in structure to 2F5 antibodies.

The study has been published in Proceedings of the National Academy of Sciences.

Source: ANI


Recommended Readings

Latest AIDS/HIV News

 HIV Antibody Response Raised in Patients With Tuberculosis Disease
A new study has found that the co-localization of tuberculosis disease and HIV in lymphatic tissues leads to the emergence of potent HIV antibodies.
Exploring the Consistent Outcomes of an Antiviral Drug
Specific antiviral drug that is widely used to treat smallpox patients since last summer's outbreak is found to produce similar outcomes regardless of the patient's HIV status.
Why Is STI and HIV Screening Decreased While Positive Test Results Increase?
In susceptible communities because of poverty, and racism, the effects of inadequate STI and HIV screening may be more profound.
Who Is Responsible for the Blunting of AIDS Epidemic?
In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.
Are Countries Missing on HIV Self-Testing?
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Novel Approach to Fight HIV may Help in Development of Vaccine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests